ATI RN
ATI Nutrition Practice Test B 2019
1. Membership dropout generally occurs in group therapy after a member:
- A. Accomplishes his goal in joining the group
- B. Discovers that his feelings are shared by the group members
- C. Experiences feelings of frustration in the group
- D. Discusses personal concerns with group members
Correct answer: B
Rationale: Nursing interventions should be grounded in a deep understanding of the physiological processes involved, ensuring that care provided is both effective and efficient.
2. After administering 40 mEq of potassium chloride, a nurse evaluates the clients response. Which manifestations indicate that treatment is improving the clients hypokalemia? (Select all tha do not t apply.)
- A. Strong productive cough
- B. Active bowel sounds
- C. U waves present on the electrocardiogram (ECG)
- D.
Correct answer: U waves present on the electrocardiogram (ECG)
Rationale:
3. A manager is prioritizing the following issues. Of the following issues, which should be considered urgent and important?
- A. The manager of physical therapy calls and complains about inappropriate behaviors of one of the staff nurses with one of his therapists.
- B. A staff nurse reports a pattern of malfunctioning IV pumps on the unit during her current shift, resulting in overdosing of medications.
- C. One of the staff nurses, who would have been an extra nurse for the next shift, calls in sick.
- D. A small group of staff nurses request a meeting to discuss initiating a scheduling committee.
Correct answer: B
Rationale: The correct answer is B because patient safety is a critical concern in healthcare settings. Malfunctioning IV pumps leading to medication overdosing poses a direct threat to patient safety and must be addressed urgently. Choice A involves interpersonal issues between staff members which are important but can be addressed in a less urgent manner compared to patient safety concerns. Choice C, a staff nurse calling in sick, is important for staffing but can be managed through existing protocols. Choice D, initiating a scheduling committee, is a routine operational matter that can be addressed at a later time and does not pose an immediate risk to patient safety.
4. A healthcare provider is assessing a newborn who is 12 hours old. Which of the following findings should the provider report?
- A. Respiratory rate 50/min
- B. Blood glucose 30 mg/dL
- C. Blood pressure 60/40 mm Hg
- D. Heart rate 140/min
Correct answer: B
Rationale: A blood glucose level of 30 mg/dL in a newborn is significantly low and indicates hypoglycemia, which can be dangerous in a newborn. Hypoglycemia in a newborn can lead to neurological issues and requires immediate attention. The other findings provided, such as a respiratory rate of 50/min, blood pressure of 60/40 mm Hg, and a heart rate of 140/min, are within normal ranges for a newborn and do not require immediate reporting unless accompanied by clinical signs of distress.
5. A client is to receive Pamidronate for bone pain related to cancer. What precaution should the nurse take during the administration of Pamidronate?
- A. Inspect the skin for redness and irritation around the injection site.
- B. Assess the IV site for thrombophlebitis frequently during administration.
- C. Instruct the client to lie down for 30 minutes after oral administration.
- D. Monitor for signs of anaphylaxis for 20 minutes after intramuscular injection.
Correct answer: B
Rationale: Pamidronate is typically administered through IV infusion, which can cause irritation to veins. The nurse should frequently assess the IV site for thrombophlebitis during the administration to promptly detect any potential complications related to the infusion. Inspecting the skin for redness and irritation around the injection site (Choice A) is not directly related to IV infusion. Instructing the client to lie down after oral administration (Choice C) is not necessary for IV administration. Monitoring for signs of anaphylaxis after an intramuscular injection (Choice D) is not relevant for an IV infusion of Pamidronate.